GLP-1 Drugs: Unveiling a Link to Slower Biological Aging
New research suggests GLP-1 receptor agonists like semaglutide may slow biological aging, impacting cellular health and offering insights into longevity pathways.
New research suggests GLP-1 receptor agonists like semaglutide may slow biological aging, impacting cellular health and offering insights into longevity pathways.